GlassScriptPhysician profile
Mena Abdelmalak
NPI 1073044590
$12,127.70
in general payments reported to CMS, 2019-2025
10 companies · $62.68 in 2025
The $62.68 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,334 · 2022: $6,474 · 2023: $2,811 · 2024: $446 · 2025: $62.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,781 · Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,780.86 |
| Food and Beverage | $1,538.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,501.14 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $4,380.03 | 2022-2024 | Eterna |
| Medtronic, INC. | $1,098.88 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $380.46 | 2023-2024 | Senza |
| Saluda Medical Americas, INC. | $246.40 | 2022-2023 | Evoke Scs |
| Mml US, INC. | $166.30 | 2022 | |
| Nalu Medical, INC. | $146.78 | 2021 | |
| Vertos Medical, INC. | $123.51 | 2023 | Mild Device Kit |
| Spr Therapeutics, INC | $66.37 | 2022-2025 | Sprint Pns System |
| Averitas Pharma INC. | $17.83 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mena Abdelmalak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.